Within-Visit Blood Pressure Variability and All-Cause and Stroke Mortality: Thai Epidemiologic Stroke Study

Log in to MyKarger to check if you already have access to this content.

Buy FullText & PDF Unlimited re-access via MyKarger Unrestricted printing, no saving restrictions for personal use read more

CHF 38.00 *
EUR 35.00 *
USD 39.00 *

Select

KAB

Buy a Karger Article Bundle (KAB) and profit from a discount!

If you would like to redeem your KAB credit, please log in.

Save over 20% compared to the individual article price.

Learn more

Access via DeepDyve Unlimited fulltext viewing Of this article Organize, annotate And mark up articles Printing And downloading restrictions apply

Select

Subscribe Access to all articles of the subscribed year(s) guaranteed for 5 years Unlimited re-access via Subscriber Login or MyKarger Unrestricted printing, no saving restrictions for personal use read more

Subcription rates

Select

* The final prices may differ from the prices shown due to specifics of VAT rules.

Article / Publication Details

First-Page Preview

Abstract of Original Paper

Received: March 26, 2022
Accepted: May 30, 2022
Published online: July 14, 2022

Number of Print Pages: 10
Number of Figures: 0
Number of Tables: 7

ISSN: 0251-5350 (Print)
eISSN: 1423-0208 (Online)

For additional information: https://www.karger.com/NED

Abstract

Introduction: The association between within-visit blood pressure variability (BPV) and all-cause and stroke mortality remains uncertain. The aim of our study was to assess the association of within-visit BPV with all-cause and stroke mortality. Methods: The study was conducted among participants from Thai Epidemiologic Stroke Study, which is a prospective community-based cohort study that recruited participants from the general population from five regions of Thailand. This study included 19,614 participants aged 45–80 years, who were free of stroke and had three blood pressure (BP) measurements, taken 1 min apart, at baseline. Within-visit systolic blood pressure (SBP) and diastolic blood pressure (DBP) variability were expressed as the maximum absolute difference (MAD) between any two readings among the three repeated sequential measurements of SBP and DBP, respectively. The participants were followed up for mortality. Cox regression analysis was used to identify the association of within-visit BPV with all-cause and stroke mortality. Hazard ratio (HR) and 95% confidence intervals were used to illustrate the associations. Sensitivity analysis restricted to participants with mean SBP above 130 mm Hg and mean DBP above 90 mm Hg (n = 1,895) was performed. Results: During a median follow-up of 11.1 years, 305 participants died of stroke, and 3,173 participants died of nonstroke cause. In unadjusted analyses, high within-visit MAD of SBP was significantly associated with all-cause (HR, 1.19; 95% CI, 1.09–1.31; p < 0.001) and stroke mortality (HR, 1.87; 95% CI, 1.35–2.59; p < 0.001); high within-visit MAD of DBP was also significantly associated with all-cause mortality (HR, 1.19; 95% CI, 1.08–1.31; p < 0.001), in quartile 4 versus quartile 1. These associations did not persist after further adjustment for sex, age, and other potential confounders including mean BP. However, sensitivity analysis showed some inconsistent results regarding associations of within-visit MAD of SBP and DBP with all-cause and stroke mortality, respectively. Conclusion: In general population, within-visit systolic BPV and within-visit diastolic BPV do not have prognostic significance on stroke mortality and all-cause mortality, respectively.

© 2022 S. Karger AG, Basel

References Meschia JF, Bushnell C, Boden-Albala B, Braun LT, Bravata DM, Chaturvedi S, et al. Guidelines for the primary prevention of stroke: a statement for healthcare professionals from the American heart association/American stroke association. Stroke. 2014;45(12):3754–832. Whelton PK, Carey RM, Aronow WS, Casey DE Jr, Collins KJ, Dennison Himmelfarb C, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: executive summary: a report of the American college of cardiology/American heart association task force on clinical practice guidelines. Hypertension. 2018;71(6):1269–324. GBD 2019 Risk Factors Collaborators. Global burden of 87 risk factors in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020;396(10258):1223–49. Parati G, Ochoa JE, Lombardi C, Bilo G. Assessment and management of blood pressure variability. Nat Rev Cardiol. 2013;10(3):143–55. Tai C, Sun Y, Dai N, Xu D, Chen W, Wang J, et al. Prognostic significance of visit-to-visit systolic blood pressure variability: a meta-analysis of 77,299 patients. J Clin Hypertens. 2015;17(2):107–15. Stevens SL, Wood S, Koshiaris C, Law K, Glasziou P, Stevens RJ, et al. Blood pressure variability and cardiovascular disease: systematic review and meta-analysis. BMJ. 2016;354:i4098. Muntner P, Whittle J, Lynch AI, Colantonio LD, Simpson LM, Einhorn PT, et al. Visit-to-visit variability of blood pressure and coronary heart disease, stroke, heart failure and mortality: a cohort study. Ann Intern Med. 2015;163(5):329–38. Gosmanova EO, Mikkelsen MK, Molnar MZ, Lu JL, Yessayan LT, Kalantar-Zadeh K, et al. Association of systolic blood pressure variability with mortality, coronary heart disease, stroke, and renal disease. J Am Coll Cardiol. 2016;68(13):1375–86. Wang J, Shi X, Ma C, Zheng H, Xiao J, Bian H, et al. Visit-to-visit blood pressure variability is a risk factor for all-cause mortality and cardiovascular disease: a systemic review and meta-analysis. J Hypertens. 2017;35(1):10–7. Dai L, Song L, Li X, Yang Y, Zheng X, Wu Y, et al. Association of visit-to-visit blood pressure variability with the risk of all-cause mortality and cardiovascular events in general population. J Clin Hypertens. 2018;20(2):280–8. Pringle E, Phillips C, Thijs L, Davidson C, Staessen JA, de Leeuw PW, et al. Systolic blood pressure variability as a risk factor for stroke and cardiovascular mortality in the elderly hypertensive population. J Hypertens. 2003;21(12):2251–7. Stolarz-Skrzypek K, Thijs L, Richart T, Li Y, Hansen TW, Boggia J, et al. Blood pressure variability in relation to outcome in the international database of ambulatory blood pressure in relation to cardiovascular outcome. Hypertens Res. 2010;33(8):757–66. Hansen TW, Thijs L, Li Y, Boggia J, Kikuya M, Bjorklund-Bodegard K, et al. Prognostic value of reading-to-reading blood pressure variability over 24 hours in 8,938 subjects from 11 populations. Hypertension. 2010;55(4):1049–57. Rothwell PM, Howard SC, Dolan E, O’Brien E, Dobson JE, Dahlof B, et al. Prognostic significance of visit-to-visit variability, maximum systolic blood pressure, and episodic hypertension. Lancet. 2010;375(9718):895–905. Papaioannou TG, Georgiopoulos G, Stamatelopoulos KS, Protogerou AD, Alexandraki KI, Argyris A, et al. Blood pressure variability within a single visit and all-cause mortality. Neth J Med. 2020;78(4):175–82. Muntner P, Levitan EB, Reynolds K, Mann DM, Tonelli M, Oparil S, et al. Within-visit variability of blood pressure and all-cause and cardiovascular mortality among US adults. J Clin Hypertens. 2012;14(3):165–71. Hanchaiphiboolkul S, Suwanwela NC, Poungvarin N, Nidhinandana S, Puthkhao P, Towanabut S, et al. Risk of metabolic syndrome for stroke is not greater than the sum of its components: Thai Epidemiologic Stroke (TES) Study. J Stroke Cerebrovasc Dis. 2013;22(8):e264–70. Puthkhao P, Hanchaiphiboolkul S, Theerawanviwat D. Factors predicting stroke mortality in Thailand: Thai epidemiologic stroke study. J Med Assoc Thai. 2020;103(12):1335–44. National Statistical Office, Thailand. Population and housing census 2000. Available from: http://web.nso.go.th/eng/en/pop2000/prelim_e.htm (accessed July 16, 2021). Hanchaiphiboolkul S, Poungvarin N, Nidhinandana S, Suwanwela NC, Puthkhao P, Towanabut S, et al. Prevalence of stroke and stroke risk factors in Thailand: Thai Epidemiologic Stroke (TES) Study. J Med Assoc Thai. 2011;94(4):427–36. Kongbunkiat K, Kasemsap N, Thepsuthammarat K, Tiamkao S, Sawanyawisuth K. National data on stroke outcomes in Thailand. J Clin Neurosci. 2015;22(3):493–7. World Health Organization. Verbal autopsy standards: ascertaining and attributing cause of death. World Health Organization; 2007. Available from: https://apps.who.int/iris/handle/10665/43764 (accessed July 16, 2021). Aho K, Harmsen P, Hatano S, Marquardsen J, Smirnov VE, Strasser T. Cerebrovascular disease in the community: results of a WHO collaborative study. Bull World Health Organ. 1980;58(1):113–30. Parati G, Stergiou GS, Dolan E, Bilo G. Blood pressure variability: clinical relevance and application. J Clin Hypertens. 2018;20(7):1133–7. Mancia G, Bombelli M, Facchetti R, Madotto F, Corrao G, Trevano FQ, et al. Long-term prognostic value of blood pressure variability in the general population: results of the Pressioni Arteriose Monitorate e Loro Associazioni Study. Hypertension. 2007;49(6):1265–70. Ma W, Yang Y, Qi L, Zhang B, Meng L, Zhang Y, et al. Relation between blood pressure variability within a single visit and stroke. Int J Hypertens. 2021;2021:2920140. Shin JH, Shin J, Kim BK, Lim YH, Park HC, Choi SI, et al. Within-visit blood pressure variability: relevant factors in the general population. J Hum Hypertens. 2013;27(5):328–34. Grassi G, Seravalle G, Maloberti A, Facchetti R, Cuspidi C, Bombelli M, et al. Within-visit BP variability, cardiovascular risk factors, and BP control in central and eastern Europe: findings from the BP-CARE study. J Hypertens. 2015;33(11):2250–6. Okada R, Yasuda Y, Tsushita K, Wakai K, Hamajima N, Matsuo S. Within-visit blood pressure variability is associated with prediabetes and diabetes. Sci Rep. 2015;5:7964. Rodrigues AB, Gismondi RA, Lagoeiro A, Cecilio AM, Vasques D, Arita R, et al. Association between B-type natriuretic peptide and within-visit blood pressure variability. Clin Cardiol. 2018;41(6):778–81. Rothwell PM, Howard SC, Dolan E, O’Brien E, Dobson JE, Dahlof B, et al. Effects of β blockers and calcium-channel blockers on within-individual variability in blood pressure and risk of stroke. Lancet Neurol. 2010;9(5):469–80. Hara A, Thijs L, Asayama K, Jacobs L, Wang JG, Staessen JA. Randomised double-blind comparison of placebo and active drugs for effects on risks associated with blood pressure variability in the systolic hypertension in Europe trial. PLoS One. 2014;9(8):e103169. Schutte R, Thijs L, Liu YP, Asayama K, Jin Y, Odili A, et al. Within-subject blood pressure level -not variability- predicts fatal and nonfatal outcomes in a general population. Hypertension. 2012;60(5):1138–47. Cai E, Chen L, Wang Y, An D, Zhang J, Tang X, et al. Predictive value of within-visit and visit-to-visit blood pressure variability for all-cause mortality: the Minhang Study. J Hypertens. 2021;39(9):1844–51. Article / Publication Details

First-Page Preview

Abstract of Original Paper

Received: March 26, 2022
Accepted: May 30, 2022
Published online: July 14, 2022

Number of Print Pages: 10
Number of Figures: 0
Number of Tables: 7

ISSN: 0251-5350 (Print)
eISSN: 1423-0208 (Online)

For additional information: https://www.karger.com/NED

留言 (0)

沒有登入
gif